Clinical Trial

The Gut - PRO Study

Not Yet Recruiting Phase 2
View on ClinicalTrials.gov →
Summary
The purpose of this study is to assess the safety and feasibility of an oral probiotic supplement (PS) intervention in individuals with dementia or mild-cognitive impairment (MCI) due to Alzheimer's disease or at risk of dementia due to Alzheimer's disease (AD). 40 participants will be enrolled and can expect to be on study for up to 1 year.
Protocol Amendment History 1 change
critical Primary endpoint(s) modified 2026-05-05
Trial Details
NCT Number NCT07413744
Lead Sponsor University of Wisconsin, Madison
Collaborators: International Flavors & Fragrances Inc., National Institute on Aging (NIA)
Conditions Alzheimer Disease
Enrollment 40 participants
Start Date 2026-08
Primary Completion 2029-03 (estimated)
Study Completion 2029-03 (estimated)
Updated on ClinicalTrials.gov 2026-07-02